We are live on ! Find out more
MRKR icon

Marker Therapeutics
MRKR

48 hedge funds and large institutions have $7.36M invested in Marker Therapeutics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.14% less ownership

Funds ownership: 2.81% → 2.66% (-0.14%)

2% less funds holding

Funds holding: 49 → 48 (-1)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

28% less capital invested

Capital invested by funds: $10.3M → $7.36M (-$2.92M)

73% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 15

Holders
48
Holders Change
-1
Holders Change %
-2.04%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
15
Closed
6
Calls
$50K
Puts
–
Net Calls
+$50K
Net Calls Change
-$13K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$48K
2
MAA
Matrix Asset Advisors
New York
+$33.3K
3
Jane Street
Jane Street
New York
+$21.7K
4
TRCT
Tower Research Capital (TRC)
New York
+$7.42K
5
VF
Virtu Financial
New York
+$5.49K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
-$150K
2
Renaissance Technologies
Renaissance Technologies
New York
-$105K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$57.1K
4
BlackRock
BlackRock
New York
-$47K
5
Millennium Management
Millennium Management
New York
-$46.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
$7K -$5.87K -1,765 -45%
WA
27
WealthTrust Axiom
Pennsylvania
$7K – – –
TRCT
28
Tower Research Capital (TRC)
New York
$7K +$7.42K +2,231 New
APA
29
American Portfolios Advisors
New York
$6.99K – – –
Morgan Stanley
30
Morgan Stanley
New York
$6K -$1.25K -375 -16%
HighTower Advisors
31
HighTower Advisors
Illinois
$6K – – –
Bank of New York Mellon
32
Bank of New York Mellon
New York
$5K – – –
RAM
33
Riggs Asset Management
Pennsylvania
$5K – – –
US Bancorp
34
US Bancorp
Minnesota
$5K – – –
VF
35
Virtu Financial
New York
$5K +$5.49K +1,651 New
Commonwealth Equity Services
36
Commonwealth Equity Services
Massachusetts
$4K -$2.68K -807 -39%
CFS
37
CRA Financial Services
New Jersey
$4K – – –
Group One Trading
38
Group One Trading
Illinois
$1K -$9.07K -2,727 -90%
UBS Group
39
UBS Group
Switzerland
$1K -$775 -233 -39%
Bank of America
40
Bank of America
North Carolina
$1K – – –
Wells Fargo
41
Wells Fargo
California
$1K +$13 +4 +1%
BNP Paribas Financial Markets
42
BNP Paribas Financial Markets
France
$79 -$23 -7 -23%
Two Sigma Advisers
43
Two Sigma Advisers
New York
– -$150K -33,980 Closed
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
– -$57.1K -17,154 Closed
Mercer Global Advisors
45
Mercer Global Advisors
Colorado
– -$20K -4,500 Closed
MM
46
Meridian Management
Arkansas
– -$9K -1,956 Closed
AWP
47
Ascent Wealth Partners
New York
– -$5K -1,027 Closed
Simplex Trading
48
Simplex Trading
Illinois
– -$765 -230 -61%
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
– +$126 +38 New
1
2

MRKR Hedge Fund Activity: Q2 2022 in Review

48 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Marker Therapeutics (MRKR) for Q2 2022, worth a combined $7.36M — down 28% from $10.3M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of MRKR and 5 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 4 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $48K. The largest seller was Two Sigma Advisers, exiting entirely with an estimated $150K sold.

  • 48 institutional investors held Marker Therapeutics (MRKR) as of Q2 2022, down from 49 in Q1 2022.
  • Funds reported $7.36M of Marker Therapeutics stock for Q2 2022, down 28% quarter-over-quarter.
  • 5 funds opened new Marker Therapeutics positions in Q2 2022 and 6 closed out, a net change of -1 holder.
  • The largest Marker Therapeutics buyer in Q2 2022 was Citadel Advisors, an estimated $48K added.
  • The largest Marker Therapeutics seller in Q2 2022 was Two Sigma Advisers, an estimated $150K sold.

Based on aggregated 13F filings for Q2 2022.